Answers are grounded in this paper and cite their sources.
Owing to its robust trans-cleavage activity, CRISPR-Cas12a is a preferred tool for biosensing, yet its native DNA-only recognition limits RNA detection. Herein, we report a simple strategy requiring neither protein mutagenesis nor exogenous factors that enables wild-type Cas12a to directly detect RNA targets. We repurposed the Cas12a recognition unit from a full-length ssDNA into a cooperative assembly of two short ssDNAs. In this assembly, a 10−11 nucleotide primer segment relieves the inherent DNA restriction, enabling robust dual-DNA/RNA recognition. Notably, this primer ssDNA modulates substrate preference solely by remodeling the ribonucleoprotein complex conformation without directly triggering trans-cleavage, which remains strictly dependent on target−crRNA complementarity. Molecular docking simulations further reveal that the crRNA−target heteroduplex induces a conformational rearrangement in the Cas12a Nuc domain, forming a catalytic channel that supports trans-cleavage. Further, we constructed a primer ssDNA-mediated Cas12a platform that detects miR-122, miR-92a, and miR-192 with high specificity and sensitivity, rendering it suitable for early clinical diagnosis. Collectively, this work establishes a minimalist, low-cost strategy to overcome Cas12a’s intrinsic RNA detection limitation, elucidates the underlying conformational mechanism, and provides a practical technological tool for rapid RNA diagnostics and integrated molecular diagnostic platforms.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: